Fig. 4From: Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the EPIRAN community-based studyCumulative incidence of death (Panel a: on the left side) and end-stage renal disease (ESRD) (Panel b: on the right side) in patients with eGFR <20Â mL/min/1.73Â m2 (solid line) and other patients (dotted line). HD: hemodialysis; eGFR: estimated glomerular filtration rate (using MDRD- modification of diet in renal disease-formula)Back to article page